kentucky glp-1 digestive blockage lawsuit semaglutide gastric intestinal obstruction law firm in office kentucky gastric intestinal obstruction kentucky semaglutide gastrointestinal obstruction law office glp-1 gastrointestinal obstruction law office in kentucky Ozempic glp-1 bowel obstruction class action

C.AtonS

Tirzepatide, a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, commonly causes gastrointestinal effects including nausea, diarrhea, and constipation

Clinical evidence (based on the literature) on GLP-1 RAs licensed in South Asia or under regulatory approval in one or more South Asian countries is presented and based on prescription pattern and the geography of the reported patient group

Selank specifically has shown anxiolytic effects through GABA and serotonin modulation without the dependence risk of benzodiazepines or the side effect profile of SSRIs